APP

Founded in 1996, APP Pharmaceuticals is a leading manufacturer of multi-source and branded injectable pharmaceutical products for acute medical care both in patient and ambulatory settings. Through continuous expansion of its’ broad portfolio of products covering a wide array of therapeutic categories, our products provide ongoing affordable healthcare helping millions of people in the United States and Canada fight critical illnesses

Headquartered in Schaumburg, Illinois, our 1,400 employees are united in their commitment to operations excellence in the ultimate effort to provide products that elevate patient care. APP™ has offices in Canada and manufacturing operations in Illinois, New York and Puerto Rico and is traded on The Nasdaq Global Market under the symbol APPX.


New Products

In the News

July 7, 2008
APP Pharmaceuticals to Be Acquired by Fresenius

July 3, 2008
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP

June 2, 2008
APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP

May 15, 2008
APP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe Supply

View More

Safety Features